Inhibitor

Bibliography

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Inhibitor Report for: Tamoxifen

Name Class
TamoxifenTypeDrug
Not A/B H target
Other_Name (9)
Chemical_Nomenclature2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
FormulaC26H29NO
MW371.51
PaperRedinbo_2005_Drug.Discov.Today_10_313
Mesange_2002_Bioconjug.Chem_13_766
de Medina_2010_Proc.Natl.Acad.Sci.U.S.A_107_13520
Fleming_2005_J.Mol.Biol_352_165
Structure1YA4
CommentTamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue (a non-steroidal estrogen receptor antagonist used to treat breast cancer), but as an estrogen (stimulating agent) in cholesterol metabolism, bone density. It is hydrolyzed by carboxylesterase
Gene_locushuman-CES1
CID2733526
FamilyCarboxylesterase
Carb_B_Chordata
InChIKeyNKANXQFJJICGDU-QPLCGJKRSA-N
CanonicalSMILESCCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3
InChIInChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-
WikipediaTamoxifen

Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer